HR Execs on the Move

Amarillo Diagnostic Clinic

www.adcpa.com

 
The pulmonary specialists at Amarillo Diagnostic Clinic specialize in treating patients with lung and respiratory disorders. Our Pulmonary Department has expanded into the diagnosis and treatment of sleep disorders. Our diagnostic facility includes
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Marco - Abrasives, Blasting

Marco - Abrasives, Blasting is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

National Toxicology Labs Inc

National Toxicology Laboratories, Inc. (NTL) is a leading forensic substance abuse drug testing facility in the United States. We provide fast, friendly and efficient drug testing service to public and private employees nationwide. NTL is a SAMHSA/DHHS

Michael Smith Genome Sciences Centre

Michael Smith Genome Sciences Centre is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Amorfix Life Sciences

Amorfix Life Sciences Ltd. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Gritstone Oncology

Gritstone Oncology is a privately-held company headquartered in the San Francisco Bay Area with key functions located in Cambridge, Massachusetts and Pleasanton, California. We launched in October 2015, and since inception, have successfully raised two large, private financing rounds. We currently employ more than 60 professionals. We have brought together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to tackle fundamental challenges at the intersection of cancer genomics and immunotherapy. With our unique approach to immuno-oncology, we are developing next-generation personalized immunotherapies to fight cancer in patients with the most difficult-to-treat tumors. We plan to combine these personalized neoantigen-targeted therapies with current immune checkpoint modulatory approaches to improve response rates and survival in patients with solid tumors.